BACE1 and Down syndrome: The observation of Aβ11pE-42 and Aβ11-42 in early, diffuse plaques in both AD but also early Downs syndrome and CUAP does not support a plaque-onset related role for BACE1 overactivation beyond a mechanism to combat an initial rise in Aβ levels.